IT201700034725A1 - Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica - Google Patents

Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica

Info

Publication number
IT201700034725A1
IT201700034725A1 IT102017000034725A IT201700034725A IT201700034725A1 IT 201700034725 A1 IT201700034725 A1 IT 201700034725A1 IT 102017000034725 A IT102017000034725 A IT 102017000034725A IT 201700034725 A IT201700034725 A IT 201700034725A IT 201700034725 A1 IT201700034725 A1 IT 201700034725A1
Authority
IT
Italy
Prior art keywords
vescicular
phospholipides
aggregates
formulations
dimensional
Prior art date
Application number
IT102017000034725A
Other languages
English (en)
Inventor
Maria Letizia Manca
Maria Manconi
Anna Maria Fadda
Original Assignee
Univ Degli Studi Cagliari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Cagliari filed Critical Univ Degli Studi Cagliari
Priority to IT102017000034725A priority Critical patent/IT201700034725A1/it
Priority to EP18163201.9A priority patent/EP3381517B1/en
Publication of IT201700034725A1 publication Critical patent/IT201700034725A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
IT102017000034725A 2017-03-29 2017-03-29 Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica IT201700034725A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102017000034725A IT201700034725A1 (it) 2017-03-29 2017-03-29 Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica
EP18163201.9A EP3381517B1 (en) 2017-03-29 2018-03-21 Phospholipid three-dimensional vesicular aggregates scattered in alcoholic mixtures with no or low water content, their preparation and use in formulations for topical application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000034725A IT201700034725A1 (it) 2017-03-29 2017-03-29 Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica

Publications (1)

Publication Number Publication Date
IT201700034725A1 true IT201700034725A1 (it) 2018-09-29

Family

ID=59683759

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000034725A IT201700034725A1 (it) 2017-03-29 2017-03-29 Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica

Country Status (2)

Country Link
EP (1) EP3381517B1 (it)
IT (1) IT201700034725A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201900004877A1 (it) * 2019-04-01 2020-10-01 Res Pharma Ind S R L Processo di preparazione di sistemi colloidali concentrati
CN115024989B (zh) * 2022-06-01 2023-03-31 浙江迪恩生物科技股份有限公司 用分子马达囊泡包裹姜黄素或四氢姜黄素的脂质体-分子马达稳定剂溶液及制备方法和应用
CN115737561B (zh) * 2022-09-16 2024-12-20 北京市中医药研究所 复方二元醇质体、其制备方法及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031196A1 (en) * 1995-04-05 1996-10-10 Imarx Pharmaceutical Corp. Novel compositions of lipids and stabilizing materials
US20050158389A1 (en) * 1999-12-30 2005-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
US20080145415A1 (en) * 2006-04-21 2008-06-19 Lanfranco Callegaro Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof
WO2010022873A2 (en) * 2008-09-01 2010-03-04 Merz Pharma Gmbh & Co. Kgaa Liposomal structures forming isometric agglomerates, especially bath beads, the production and use thereof
EP3025732A1 (en) * 2014-11-27 2016-06-01 Icnoderm Srl Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031196A1 (en) * 1995-04-05 1996-10-10 Imarx Pharmaceutical Corp. Novel compositions of lipids and stabilizing materials
US20050158389A1 (en) * 1999-12-30 2005-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
US20080145415A1 (en) * 2006-04-21 2008-06-19 Lanfranco Callegaro Bioresorbable Fillers Constituted by Phospholipid Liposomes and Hyaluronic Acid and/or the Derivatives Thereof
WO2010022873A2 (en) * 2008-09-01 2010-03-04 Merz Pharma Gmbh & Co. Kgaa Liposomal structures forming isometric agglomerates, especially bath beads, the production and use thereof
EP3025732A1 (en) * 2014-11-27 2016-06-01 Icnoderm Srl Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CASTANGIA INES ET AL: "Effects of ethanol and diclofenac on the organization of hydrogenated phosphatidylcholine bilayer vesicles and their ability as skin carriers", JOURNAL OF MATERIALS SCIENCE: MATERIALS IN MEDICINE, SPRINGER NEW YORK LLC, UNITED STATES, vol. 26, no. 3, 26 February 2015 (2015-02-26), pages 1 - 9, XP035457431, ISSN: 0957-4530, [retrieved on 20150226], DOI: 10.1007/S10856-015-5443-1 *
CASTANGIA INES ET AL: "Faceted phospholipid vesicles tailored for the delivery ofSantolina insularisessential oil to the skin", COLLOIDS AND SURFACES. B, BIOINTERFACES, ELSEVIER, AMSTERDAM, NL, vol. 132, 22 May 2015 (2015-05-22), pages 185 - 193, XP029189590, ISSN: 0927-7765, DOI: 10.1016/J.COLSURFB.2015.05.025 *
MANCA MARIA LETIZIA ET AL: "Molecular arrangements and interconnected bilayer formation induced by alcohol or polyalcohol in phospholipid vesicles", COLLOIDS AND SURFACES. B, BIOINTERFACES, vol. 117, 12 March 2014 (2014-03-12), pages 360 - 367, XP028643378, ISSN: 0927-7765, DOI: 10.1016/J.COLSURFB.2014.03.010 *

Also Published As

Publication number Publication date
EP3381517A1 (en) 2018-10-03
EP3381517B1 (en) 2022-03-16

Similar Documents

Publication Publication Date Title
MA43439A (fr) Nouveaux peptides et combinaison de peptides destinés à être utilisés en immunothérapie contre diverses tumeurs (seq id 253 - rad54b)
CL2016002416A1 (es) Composiciones estables de yodo no en complejo y métodos de uso
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
EA201790378A1 (ru) Заключенное в липосому аффинное лекарственное средство
BR112017008499A2 (pt) métodos e composições relacionadas com o uso de tensoativos de baixo valor de hlb na produção de nanoportadores sintéticos compreendendo um rapalog
WO2015075557A3 (en) C/ebp alpha short activating rna compositions and methods of use
EA202090547A2 (ru) Макроциклические деаза-оксипурины для лечения вирусных инфекций
MX363347B (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
PH12016501122B1 (en) Delayed release compositions of linaclotide
SI3800177T1 (sl) Sestavki fenfluramina in njihovi načini priprave
HK1220445A1 (zh) 具有摇溶性以及增强的溶解再现性和稳定性的组合物
PT3423076T (pt) Formulações tópicas contendo ciclosporina e respetivas utilizações
WO2014159669A3 (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
CL2014001959A1 (es) Compuestos derivados de fenil-1h-imidazo[1,2-b]pirazol sustituidos; procedimiento de preparacion; composicion farmaceutica; y el uso en el tratamiento del cancer.
PL3551617T3 (pl) Kompozycje i sposoby związane z pirydynoilopiperydynowymi agonistami 5-HT<sub>1F</sub>
IT201700034725A1 (it) Aggregati vescicolari tridimensionali di fosfolipidi dispersi in miscele alcoliche a basso o nullo contenuto d’acqua, loro preparazione e loro uso in formulazioni per applicazione topica
BR112016018371A2 (pt) derivado de indolona substituído com pirrol, método de preparação do mesmo, composição compreendendo o mesmo e uso do mesmo
BR112014025416A2 (pt) AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS.
CR20120461A (es) Hidrato del hidrobromuro de agomelatina y preparación de éste
MX372607B (es) Sal de succinato de citisina y uso de la misma
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
WO2014144153A3 (en) Metapneumovirus immunogens and related materials and methods
IL243908A0 (en) Mixtures for concrete production and processes for their preparation
BR112017021120A2 (pt) forma de dosagem de combinação de um antagonista de receptor mu opioide e um agente opioide
CL2014003028A1 (es) Formulacion parenteral de clorhidrato de esmolol; metodo de produccion; kit farmaceutico; uso para tratar descompensacion cardiaca y/o renal y/o hipernatremia y/o acidosis hipercloramica.